Saltar al contenido
Merck

Deficiency of protocadherin 9 leads to reduction in positive emotional behaviour.

Scientific reports (2022-07-14)
Masato Uemura, Tamio Furuse, Ikuko Yamada, Tomoko Kushida, Takaya Abe, Keiko Imai, Soichi Nagao, Moeko Kudoh, Katsuhiko Yoshizawa, Masaru Tamura, Hiroshi Kiyonari, Shigeharu Wakana, Shinji Hirano
RESUMEN

Protocadherin 9 (Pcdh9) is a member of the cadherin superfamily and is uniquely expressed in the vestibular and limbic systems; however, its physiological role remains unclear. Here, we studied the expression of Pcdh9 in the limbic system and phenotypes of Pcdh9-knock-out mice (Pcdh9 KO mice). Pcdh9 mRNA was expressed in the fear extinction neurons that express protein phosphatase 1 regulatory subunit 1 B (Ppp1r1b) in the posterior part of the basolateral amygdala (pBLA), as well as in the Cornu Ammonis (CA) and Dentate Gyrus (DG) neurons of the hippocampus. We show that the Pcdh9 protein was often localised at synapses. Phenotypic analysis of Pcdh9 KO mice revealed no apparent morphological abnormalities in the pBLA but a decrease in the spine number of CA neurons. Further, the Pcdh9 KO mice were related to features such as the abnormal optokinetic response, less approach to novel objects, and reduced fear extinction during recovery from the fear. These results suggest that Pcdh9 is involved in eliciting positive emotional behaviours, possibly via fear extinction neurons in the pBLA and/or synaptic activity in the hippocampal neurons, and normal optokinetic eye movement in brainstem optokinetic system-related neurons.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Roche
Kit de etiquetado de ARN DIG (SP6/T7), sufficient for 2 x 10 labeling reactions, kit of 1 (12 components), suitable for hybridization, suitable for Southern blotting